# New Treatment for Donor Sites

> **NCT00591916** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **The University of Texas Medical Branch, Galveston**

## Conditions studied

- Burn

## Interventions

- **DRUG:** Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)]
- **PROCEDURE:** Blood sample
- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT00591916
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-01
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Donor site material (scarlet red ) came back on the market, therefore new treatements for donor sites was not needed.
- **Last updated:** 2012-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00591916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00591916, "New Treatment for Donor Sites". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00591916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*